Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edouard Louis

Showing results (221-230 of 290) with videos related to

Pageof 29
Sort By:
Journal of Crohn'S & Colitis|April 17, 2019
Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn's Disease Who Failed Biologic Therapies: A National Cohort StudyClaire Liefferinckx, Bram Verstockt, Ann Gils, et al.
Maedica|December 5, 2019
Environmental Factors in Romanian and Belgian Patients with Inflammatory Bowel Disease - a Retrospective Comparative StudyCarmen Monica Preda, Teodora Manuc, Doina Istratescu, et al.
Nature Communications|October 15, 2017
CCDC88B is required for pathogenesis of inflammatory bowel diseaseNassima Fodil, Neda Moradin, Vicki Leung, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 29, 2021
Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX TrialDavid Laharie, Geert D'Haens, Maria Nachury, et al.
The New England Journal of Medicine|May 24, 2023
Upadacitinib Induction and Maintenance Therapy for Crohn's DiseaseEdward V Loftus, Julian Panés, Ana P Lacerda, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2024
Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic ExposureLaurent Peyrin-Biroulet, Remo Panaccione, Edouard Louis, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 3, 2016
Paediatric Crohn Disease: Disease Activity and Growth in the BELCRO Cohort After 3 Years Follow-upElisabeth De Greef, Ilse Hoffman, Francoise Smets, et al.
Journal of Crohn'S & Colitis|January 13, 2025
Risankizumab efficacy and safety based on prior inadequate response or intolerance to advanced therapy: post hoc analysis of the INSPIRE and COMMAND phase 3 studiesRemo Panaccione, Edouard Louis, Jean-Frederic Colombel, et al.
Gastroenterology|August 8, 2022
Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled TrialMarie Truyens, Triana Lobatón, Marc Ferrante, et al.
The American Journal of Gastroenterology|December 6, 2012
Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion processLaurent Peyrin-Biroulet, Vincent Billioud, Geert D'Haens, et al.
Pageof 29

Showing results (221-230 of 290) with videos related to

Sort By:
Pageof 29
Journal of Crohn'S & Colitis|April 17, 2019
Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn's Disease Who Failed Biologic Therapies: A National Cohort StudyClaire Liefferinckx, Bram Verstockt, Ann Gils, et al.
Maedica|December 5, 2019
Environmental Factors in Romanian and Belgian Patients with Inflammatory Bowel Disease - a Retrospective Comparative StudyCarmen Monica Preda, Teodora Manuc, Doina Istratescu, et al.
Nature Communications|October 15, 2017
CCDC88B is required for pathogenesis of inflammatory bowel diseaseNassima Fodil, Neda Moradin, Vicki Leung, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 29, 2021
Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX TrialDavid Laharie, Geert D'Haens, Maria Nachury, et al.
The New England Journal of Medicine|May 24, 2023
Upadacitinib Induction and Maintenance Therapy for Crohn's DiseaseEdward V Loftus, Julian Panés, Ana P Lacerda, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2024
Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic ExposureLaurent Peyrin-Biroulet, Remo Panaccione, Edouard Louis, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 3, 2016
Paediatric Crohn Disease: Disease Activity and Growth in the BELCRO Cohort After 3 Years Follow-upElisabeth De Greef, Ilse Hoffman, Francoise Smets, et al.
Journal of Crohn'S & Colitis|January 13, 2025
Risankizumab efficacy and safety based on prior inadequate response or intolerance to advanced therapy: post hoc analysis of the INSPIRE and COMMAND phase 3 studiesRemo Panaccione, Edouard Louis, Jean-Frederic Colombel, et al.
Gastroenterology|August 8, 2022
Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled TrialMarie Truyens, Triana Lobatón, Marc Ferrante, et al.
The American Journal of Gastroenterology|December 6, 2012
Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion processLaurent Peyrin-Biroulet, Vincent Billioud, Geert D'Haens, et al.
Pageof 29